The Impact of the CHA² DS² -VASc Score on Recurrence of Atrial Fibrillation after a Single Catheter Ablation and Atrial Remodeling in Patients with Non-Valvular Atrial Fibrillation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: This study aimed to evaluate the impact of the CHA² DS² -VASc score on atrial fibrillation (AF) recurrence after a single catheter ablation procedure in patients with non-valvular AF. We also investigated the correlation between CHA² DS² -VASc score and atrial substrate. Subjects and Methods: This study evaluated 151 patients who underwent catheter ablation of non-valvular AF. The study population was stratified into group 1 (<2, n=72) and group 2 (≥2, n=79) by CHA² DS² -VASc score. The CHA² DS² -VASc score was analyzed as a continuous and categorical value for evaluating its impact on AF recurrence after catheter ablation. The left atrial voltage data were analyzed by the categorical values of this score. Results: Post-ablation recurrence (31.6% vs. 18.1%, p=0.046) was observed more frequently in group 2. The mean area of the low-voltage zone was 75.64±24.81 cm2 and 94.44±28.09 cm2 in groups 1 and 2, respectively (p=0.005). The left atrial mean voltage in group 2 was 0.99±0.31 mV, significantly lower than that (1.49±0.67 mV, p=0.001) in group 1. The CHA² DS² -VASc score was the independent predictor with a modest predictive value for AF recurrence after catheter ablation. Conclusion: Our study showed that CHA² DS² -VASc score was associated with atrial remodeling and could be useful in stratifying post-ablation recurrence in patients with non-valvular AF.
Abstract
Background and Objectives: This study aimed to evaluate the impact of the CHA² DS² -VASc score on atrial fibrillation (AF) recurrence after a single catheter ablation procedure in patients with non-valvular AF. We also investigated the correlation between CHA² DS² -VASc score and atrial substrate. Subjects and Methods: This study evaluated 151 patients who underwent catheter ablation of non-valvular AF. The study population was stratified into group 1 (<2, n=72) and group 2 (≥2, n=79) by CHA² DS² -VASc score. The CHA² DS² -VASc score was analyzed as a continuous and categorical value for evaluating its impact on AF recurrence after catheter ablation. The left atrial voltage data were analyzed by the categorical values of this score. Results: Post-ablation recurrence (31.6% vs. 18.1%, p=0.046) was observed more frequently in group 2. The mean area of the low-voltage zone was 75.64±24.81 cm2 and 94.44±28.09 cm2 in groups 1 and 2, respectively (p=0.005). The left atrial mean voltage in group 2 was 0.99±0.31 mV, significantly lower than that (1.49±0.67 mV, p=0.001) in group 1. The CHA² DS² -VASc score was the independent predictor with a modest predictive value for AF recurrence after catheter ablation. Conclusion: Our study showed that CHA² DS² -VASc score was associated with atrial remodeling and could be useful in stratifying post-ablation recurrence in patients with non-valvular AF.
참고문헌 (15)
- European Heart Rhythm Association, "Guidelines for the management of atrial fibrillation : the task force for the management of atrial fibrillation of the European Society of Cardiology(ESC)", Eur Heart J, 31, pp.2369~2429 (2010)
- Calkins H, "Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation : two systematic literature reviews and meta-analyses", Circ Arrhythm Electrophysiol, 2, pp.349~361 (2009)
- Balk EM, "Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation : a systematic review", J Cardiovasc Electrophysiol, 21, pp.1208~1216 (2010)
- Calkins H, "2012 HRS", EHRA, Europace, pp.2012, 14[DOI]
- Jiamsripong P, "Three methods for evaluation of left atrial volume", Eur J Echocardiogr, 9, pp.351~355 (2008)
- Chao TF, "Associations among the CHADS2 score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation", Heart Rhythm, 8, pp.1155~1159 (2011)
- Nattel S, "Atrial remodeling and atrial fibrillation: mechanisms and implications", Circ Arrhythm Electrophysiol, 1, pp.62~73 (2008)
- Akoum N, "Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach", J Cardiovasc Electrophysiol, 22, pp.16~22 (2011)
- Jiang Z, "Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: a meta-analysis", Clin Cardiol, 36, pp.548~554 (2013)
- Berkowitsch A, "Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation : a long term follow-up", Pacing Clin Electrophysiol, 35, pp.532~543 (2012)
- Letsas KP, "CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation", Europace, 16, pp.202~207 (2014)
- Verma A, "Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation : an independent predictor of procedural failure", J Am Coll Cardiol, 45, pp.285~292 (2005)
- Chao TF, "Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose", Am J Cardiol, 106, pp.1615~1620 (2010)
- Xu Y, "Atrial remodeling: new pathophysiological mechanism of atrial fibrillation", Med Hypotheses, 80, pp.53~56 (2013)
- Tuan TC, "The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation", J Cardiovasc Electrophysiol, 21, pp.966~972 (2010)